Skip to content
Fusion Antibodies Plc icon

Fusion Antibodies Plc

FAB.LStocksMedical Or Nursing ServicesUnited KingdomLSE_AIMGBP

Price

£11.00

Today

+0.0%

YTD

-18.4%

About

Fusion Antibodies Plc is a biotechnology research company based in Northern Ireland, providing a range of antibody generation and discovery services. Its primary aim is to support clients in the pharmaceutical and biotechnology industries in developing novel therapeutic antibodies. The company offers its services with an international scope. Operating within the healthcare sector, Fusion Antibodies Plc focuses on delivering high-quality antibody engineering and development solutions. The goal is to accelerate the research and development pipeline for next-generation antibody-based therapies for various conditions and needs. Keep up to date on the latest share price changes by adding FAB.L stock to your eToro watchlist. This content was generated by artificial intelligence. We cannot guarantee the accuracy, completeness, or timeliness of the information provided.

Price chart
Closing price history for FAB.L (1D candles).
Open positions
Current open positions for this instrument from your live portfolio.

Open positions

0

Unrealized return

+0.0%

No open positions exist for this instrument at the moment.

Financial insights

Valuation

P/E (TTM)-4.07
P/S (TTM)4.05
P/B (TTM)6.89
Market cap$7.34M
Cap tierMicro-cap
Industry avg P/E25.74

Profitability

Gross margin11.65%
EBIT margin-92.51%
Net margin-62.80%
ROE-129.49%
ROA-90.74%

Earnings & Revenue

Revenue (TTM)$1.80M
Revenue growth (1Y)+14.1%
EPS (TTM)-$0.02
Free cash flow$-1.17M
Total debt$32,000.00

Dividends & Risk

Dividend rate$0.00
Dividend yield0.00%
Beta (5Y)-0.65
EmployeesUnknown
Trade history

Closed trades

0

Realized return

+0.0%

No stored closed trades exist for this instrument yet.

Fusion Antibodies Plc (FAB.L) | Dirk Kuyken